Literature DB >> 8401947

Selective inactivation of muscarinic M2 and M3 receptors in guinea-pig ileum and atria in vitro.

R M Eglen1, G C Harris.   

Abstract

1. The role of muscarinic M2 and M3 receptors in ileal smooth muscle has been evaluated by use of selective receptor alkylation. The alkylating agents, 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine (4-DAMP mustard) was studied for effects against (+)-cis-dioxolane, at muscarinic M2 and M3 receptors in guinea-pig atria or ileum, respectively. 4-DAMP mustard (10 nM, 40 min exposure) did not discriminate between these muscarinic receptors. In ileum, 4-DAMP mustard, at 100 nM, resulted in a large dextral shift (197 fold) and depression in maxima. In atria there was a smaller dextral shift (14 fold) but no depression in maxima. 2. The muscarinic antagonists, atropine (non-selective), methoctramine (M2-selective) and para-fluorohexahydro-siladiphenidol (pFHHSiD; M3 selective) were studied in protection studies against alkylation by phenoxybenzamine. Washout studies following equilibration of the tissues with atropine (30 nM), methoctramine (0.3 microM) or pFHHSiD (3 microM), showed the compounds to be reversible. No temporal changes in sensitivity to (+)-cis-dioxolane were observed. 3. Exposure, for 20 min, of atria and ileum to phenoxybenzamine (3 and 10 microM respectively) caused dextral shifts and depressions in the maxima of the concentration-response curve to (+)-cis-dioxolane. These effects were inhibited by prior equilibration with atropine (30 nM) and methoctramine (0.1 microM) in atria or atropine (30 nM) and pFHHSiD (3 microM) in ileum. Similar results in ileum were obtained when pilocarpine was used as the agonist. 4. These data were consistent with muscarinic M2 receptors mediating responses in atria and M3 receptors mediating responses in ileum. No evidence was provided for a direct role of muscarinic M2 receptors in ileal contraction.5. It is concluded that receptor protection by reversible antagonists for muscarinic M2 or M3 receptors provides a means to isolate pharmacologically a single subtype in a tissue possessing heterogeneous populations. This technique may prove useful in defining the role of the respective subtypes in smooth muscle contraction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8401947      PMCID: PMC2175728          DOI: 10.1111/j.1476-5381.1993.tb13712.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Characterization of muscarinic receptors in dog tracheal smooth muscle cells.

Authors:  C M Yang
Journal:  J Auton Pharmacol       Date:  1991-02

2.  Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.

Authors:  L M Candell; S H Yun; L L Tran; F J Ehlert
Journal:  Mol Pharmacol       Date:  1990-11       Impact factor: 4.436

3.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists.

Authors:  R B Parker; D R Waud
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

4.  Comparison of the muscarinic receptors of the guinea-pig oesophageal muscularis mucosae and trachea in vitro.

Authors:  R M Eglen; R L Whiting
Journal:  J Auton Pharmacol       Date:  1988-09

5.  The M2 selective antagonist AF-DX 116 shows high affinity for muscarine receptors in bovine tracheal membranes.

Authors:  A F Roffel; W G in't Hout; R A de Zeeuw; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

6.  The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro.

Authors:  R M Eglen; A D Michel; W W Montgomery; E A Kunysz; C A Machado; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

7.  Identification of muscarinic receptor subtypes present in cerebellar granule cells: prevention of [3H]propylbenzilyl choline mustard binding with specific antagonists.

Authors:  S W McLeskey; W J Wojcik
Journal:  Neuropharmacology       Date:  1990-09       Impact factor: 5.250

8.  The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.

Authors:  R M Eglen; W W Montgomery; I A Dainty; L K Dubuque; R L Whiting
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

9.  Some differential effects of 4-diphenylacetoxy-N-(2-chloroethyl)-piperidine hydrochloride on guinea-pig atria and ileum.

Authors:  R B Barlow; M K Shepherd; M A Veale
Journal:  J Pharm Pharmacol       Date:  1990-06       Impact factor: 3.765

10.  Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.

Authors:  E Giraldo; M A Viganò; R Hammer; H Ladinsky
Journal:  Mol Pharmacol       Date:  1988-06       Impact factor: 4.436

View more
  12 in total

1.  The role of M(2)-muscarinic receptors in mediating contraction of the pig urinary bladder in vitro.

Authors:  T Yamanishi; C R Chapple; K Yasuda; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 3.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

4.  Allosteric modulation of the M₃ muscarinic receptor by amiodarone and N-ethylamiodarone: application of the four-ligand allosteric two-state model.

Authors:  Edward Stahl; Gwendolynne Elmslie; John Ellis
Journal:  Mol Pharmacol       Date:  2011-05-20       Impact factor: 4.436

5.  Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins.

Authors:  L Walch; J P Gascard; E Dulmet; C Brink; X Norel
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

6.  Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype.

Authors:  M Matsui; D Motomura; H Karasawa; T Fujikawa; J Jiang; Y Komiya; S Takahashi; M M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

7.  In vitro effects of bethanechol on specimens of intestinal smooth muscle obtained from the duodenum and jejunum of healthy dairy cows.

Authors:  Julia B R Pfeiffer; Meike Mevissen; Adrian Steiner; Christopher J Portier; Mireille Meylan
Journal:  Am J Vet Res       Date:  2007-03       Impact factor: 1.156

8.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

9.  Characterization of the interaction between muscarinic M2 receptors and beta-adrenoceptor subtypes in guinea-pig isolated ileum.

Authors:  H Reddy; N Watson; A P Ford; R M Eglen
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

10.  Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.

Authors:  P M Kerr; K Hillier; R M Wallis; C J Garland
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.